Davies et al. [28] developed HRDetect to classify BRCA1/BRCA2-deficient breast, ovarian, and pancreatic cancer based on a LASSO logistic regression model that included mutational signatures, LOH, and indels from WGS as input. Here, BRCA2 is linked to pancreatic neoplasm.